News
Genome editing is one of the ways to defeat cancer
18.01.2021

For the first time scientists have successfully used CRISPR-Cas9 genome editing technology to treat malignant tumors.

Development of a new powerful antibiotic agent
15.01.2021

Scientists from America have managed to develop a promising compound - T405, which can destroy an extremely dangerous pathogen Mycobacterium abscessus, which is resistant to existing antibiotics.

Ananta Medicare took part in the scientific and practical forum
13.01.2021

On December 22, 2020, Ananta Medicare took part in the pharmaceutical scientific and practical forum "Sanitary and quarantine requirements for the work of pharmacies due to COVID-19 pandemic", which was held under the patronage of the main department of the State Food Service in the Rivne region.

Roflumilast foam helped to reduce psoriasis symptoms
11.01.2021

Arcutis Therapeutics has successfully tested its own drug roflumilast foam in patients with the scalp and body psoriasis.

New drug for targeted therapy for lung cancer
04.01.2021

A European regulatory body will consider Merck's tepotinib for use in certain types of tumors.

Creation of piroxicam nanoform
28.12.2020

The first clinical trial of Nanoform Piroxicam manuractured by the Finnish company will begin at the end of 2020.

Paroxetine may have anti-cancer effects
22.12.2020

Scientists from Sweden Karolinska Institute have found that a common and often prescribed antidepressant can stop the growth of a malignant tumor.

Staphylococcus aureus may be a cure
15.12.2020

Scientists have discovered a bacterial toxin that promotes tissue healing.